Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective?

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 1, 2008, Pages 40-43

  Mcmahon, James H ^a,b   O'keeffe, Jason M ^a   Lindsay, Grayson M ^a,c,d  

^a AUSTIN HEALTH   (Australia)

^b PENINSULA HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; FLUCLOXACILLIN; GENTAMICIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT;

ADULT; ARTICLE; AUSTRALIA; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOME CARE; HUMAN; MALE; MONOTHERAPY; NEPHROTOXICITY; NONHUMAN; PATIENT SELECTION; PROSPECTIVE STUDY; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; THORAX PAIN;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AUSTRALIA; ENDOCARDITIS, BACTERIAL; FEMALE; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 37749041540     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701522942     Document Type: Article

References (13)

1. Andrews, MM and Von Reyn, CF. (2001) Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis, 33, pp. 203-209.
2. Grayson, ML, Silvers, J. and Turnidge, J. (1995) Home intravenous antibiotic therapy. A safe and effective alternative to inpatient care. Med J Aust, 162, pp. 249-253.
3. Leder, K., Turnidge, JD, Korman, TM and Grayson, ML. (1999) The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. J Antimicrob Chemother, 43, pp. 113-118.
4. Howden, BP and Richards, MJ. (2001) The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitis. J Antimicrob Chemother, 48, pp. 311-314.
5. Stamboulian, D., Bonvehi, P., Arevalo, C., Bologna, R., Cassetti, I. and Scilingo, V. (1991) Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis, 13, p. S160.
6. Francioli, P., Etienne, J., Hoigne, R., Thys, JP and Gerber, A. (1992) Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA, 267, pp. 264-267.
7. Francioli, P., Ruch, W. and Stamboulian, D. (1995) Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 d: A prospective multicentre study. Clin Infect Dis, 21, pp. 1406-1410.
8. Durack, DT, Lukes, AS and Bright, DK. (1994) New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med, 96, pp. 200-209.
9. Lopardo, G. (2001) Management of endocarditis: Outpatient parenteral antibiotic treatment in Argentina. Chemotherapy, 47, pp. 24-32.
10. Mandell, GL, Bennett, JE and Dolin, R. (2005) Principles and Practice of Infectious Diseases, Chuchill Livingstone
11. Miro, JM, Anguera, I., Cabell, CH, Chen, AY, Stafford, JA and Corey, GR (2005) Staphylococcus aureus native valve infective endocarditis: Report of 566 episodes from the International Collaboration on Endocarditis merged database. Clin Infect Dis, 41, pp. 507-514.
12. Huminer, D., Bishara, J. and Pitlik, S. (1999) Home intravenous antibiotic therapy for patients with infective endocarditis. Eur J Clin Microbiol Infect Dis, 18, pp. 330-334.
13. Cabell, CH and Abrutyn, E. (2002) Progress towards a global understanding of infective endocarditis: Early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin N Am, 16, pp. 255-272.